Biogen Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $970.1M | $783.2M | $638.2M |
| Depreciation & Amortization | $428.0M | $462.1M | $380.3M |
| Depreciation | $137.9M | $129.1M | — |
| Amortization | $289.8M | $332.7M | $257.5M |
| Stock-Based Compensation | $160.9M | $146.2M | $123.1M |
| Net Cash from Operating Activities | $1.07B | $1.56B | $1.02B |
| Investing Activities | |||
| Capital Expenditures | $165.6M | $276.0M | $284.1M |
| Business Acquisitions | $0 | $25.0M | $95.8M |
| Net Cash from Investing Activities | $-395.0M | $-365.9M | $-286.6M |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | $751.2M | $738.9M | $2.99B |
| Net Cash from Financing Activities | $-724.2M | $-1.23B | $-733.3M |
| Net Change in Cash | $-44.3M | $-38.1M | $-1.2M |
| Free Cash Flow | $909.3M | $1.29B | $734.6M |